Table 1 Basic patient and lesion characteristics
From: Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3–5 lesions
Characteristics | Benign lesions | Malignant lesions | ||
|---|---|---|---|---|
n = 146 | % | n = 67 | % | |
Age (years) | ||||
median | 54 | 65 | ||
range | 18–89 | 26–89 | ||
Lesion size (mm) | ||||
median | 10 | 17 | ||
range | 3–34 | 5–50 | ||
Side | ||||
left | 89 | 61% | 27 | 40.3% |
right | 57 | 39% | 39 | 58.2% |
left and right | 0 | 0% | 1 | 1.5% |
Tumor Grade | ||||
1 | – | – | 9 | 13.4% |
2 | – | – | 33 | 49.3% |
3 | – | – | 25 | 37.3% |
Histology of benign lesions | n = 74 | – | – | |
fibrocystic disease | 32 | 43% | – | – |
benign proliferative breast disease | 12 | 16% | – | – |
fibroepithelial tumor | 11 | 15% | – | – |
intraductal proliferative lesion | 10 | 14% | – | – |
others | 9 | 12% | – | – |
Histology of malignant lesions | – | – | n = 67 | |
invasive carcinoma NST | – | – | 40 | 60% |
invasive lobular carcinoma | – | – | 13 | 19% |
others | – | – | 14 | 21% |